Search results
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 hour agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 4 hours agoBeyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 5 days agoModerna stock is yo-yoing after the company unveiled early-stage test results for its...
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 4 days agoModerna (MRNA) doesn't possess the right combination of the two key ingredients for a likely...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 5 days agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Moderna stock closes in green after eight sessions of losses (NASDAQ:MRNA)
Seeking Alpha· 7 days agoMaddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) closed in green and snapped an eight-day losing...
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 5 hours agoOther companies, including Moderna and Pfizer, are working on similar projects and are ahead of...
Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now
Motley Fool via Yahoo Finance· 8 hours agoAnd still others, such as biotech Moderna, are using the technology to streamline their own...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 3 days agoModerna (NASDAQ: MRNA) stock soared earlier in the pandemic as the company developed its coronavirus vaccine and the product went on to generate billions...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant portion of his...